| Authors | Samia Mourah, Gwenaël Lorillon, Véronique Meignin, Laetitia Vercellino, Constance de Margerie-Mellon, Cécile Pages, Lauriane Goldwirt, Alexandre How-Kit, Jorg Tost, Céleste Lebbe, Abdellatif Tazi |
| Journal | Blood
(Blood)
Vol. 126
Issue 24
Pg. 2649-52
(Dec 10 2015)
ISSN: 1528-0020 [Electronic] United States |
| PMID | 26468227
(Publication Type: Case Reports, Letter)
|
| Chemical References |
- Antineoplastic Agents
- Azetidines
- Imidazoles
- Indoles
- Neoplasm Proteins
- Oximes
- Piperidines
- Protein Kinase Inhibitors
- Proto-Oncogene Proteins
- Sulfonamides
- Vemurafenib
- Vincristine
- Doxorubicin
- Cyclophosphamide
- BRAF protein, human
- Proto-Oncogene Proteins B-raf
- MAP Kinase Kinase Kinases
- MAP3K8 protein, human
- cobimetinib
- dabrafenib
- Prednisone
|
| Topics |
- Antineoplastic Agents
(therapeutic use)
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage, therapeutic use)
- Azetidines
(administration & dosage)
- Cyclophosphamide
(administration & dosage)
- Doxorubicin
(administration & dosage)
- Drug Resistance, Neoplasm
- Drug Substitution
- Humans
- Imidazoles
(therapeutic use)
- Indoles
(administration & dosage)
- Langerhans Cell Sarcoma
(diagnostic imaging, drug therapy, genetics, pathology)
- Lymph Nodes
(diagnostic imaging, pathology)
- MAP Kinase Kinase Kinases
(antagonists & inhibitors, biosynthesis, genetics)
- Male
- Middle Aged
- Molecular Targeted Therapy
- Multimodal Imaging
- Mutation, Missense
- Neoplasm Proteins
(antagonists & inhibitors, genetics)
- Oximes
(therapeutic use)
- Piperidines
(administration & dosage)
- Point Mutation
- Positron-Emission Tomography
- Prednisone
(administration & dosage)
- Protein Kinase Inhibitors
(therapeutic use)
- Proto-Oncogene Proteins
(antagonists & inhibitors, biosynthesis, genetics)
- Proto-Oncogene Proteins B-raf
(antagonists & inhibitors, genetics)
- Recurrence
- Sulfonamides
(administration & dosage)
- Tomography, X-Ray Computed
- Vemurafenib
- Vincristine
(administration & dosage)
|
